Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden · Delayed Price · Currency is SEK 0.0080
-0.0010 (-11.11%)
At close: Sep 15, 2025
Diagonal Bio AB Revenue
Diagonal Bio AB had revenue of 284.00K SEK in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 1.36M, down -22.09% year-over-year. In the year 2024, Diagonal Bio AB had annual revenue of 1.13M, down -64.30%.
Revenue (ttm)
1.36M
Revenue Growth
-22.09%
P/S Ratio
9.66
Revenue / Employee
339.50K
Employees
5
Market Cap
13.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.13M | -2.03M | -64.30% |
| Dec 31, 2023 | 3.15M | -555.00K | -14.98% |
| Dec 31, 2022 | 3.71M | -4.96M | -57.25% |
| Dec 31, 2021 | 8.67M | 672.67K | 8.41% |
| Dec 31, 2020 | 8.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.37B |
| Getinge AB | 35.50B |
| Camurus AB | 2.27B |
| Medicover AB | 25.22B |
| Asker Healthcare Group AB | 15.88B |
| BioArctic AB | 1.86B |
| AddLife AB | 10.44B |